about
Carcinoid tumorsExogenous Molecular Probes for Targeted Imaging in Cancer: Focus on Multi-modal Imaging.Insulinoma in a third-trimester pregnant woman combined with pre-eclampsia: a case report and review of the diagnostic strategies.Peptide-based probes for targeted molecular imaging.Peptides and peptide hormones for molecular imaging and disease diagnosisPrimary hepatic neuroendocrine tumors: multi-modal imaging features with pathological correlations.Feasibility of imaging esophageal cancer with labeled somatostatin analoguePrimary hepatic neuroendocrine tumor with multiple liver metastases: A case report with review of the literature.Results of (68)Gallium-DOTATATE PET/CT Scanning in Patients with Multiple Endocrine Neoplasia Type 1.Receptor-mediated tumor targeting with radiopeptides. Part 1. General concepts and methods: applications to somatostatin receptor-expressing tumors.Molecular probes for the in vivo imaging of cancer.Small Bowel Carcinoids: A Single Surgeon's Experience in Southern IndiaProspective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary SitesClinical utility of indigenously formulated single-vial lyophilized HYNIC-TOC kit in evaluating Gastro-entero Pancreatic neuro endocrine tumours.Somatostatin receptor SPECT.Role of PET/CT in the functional imaging of endocrine pancreatic tumors.Pancreatic neuroendocrine neoplasms: diagnosis and management.State-of-the-art Imaging of Pancreatic Neuroendocrine TumorsRadiolabeled new somatostatin analogs conjugated to DOMA chelator used as targeted tumor imaging agent: synthesis and radiobiological evaluation.Synthesis, radiolabeling, and preclinical evaluation of a new octreotide analog for somatostatin receptor-positive tumor scintigraphy.Differentiated expression of somatostatin receptor subtypes in experimental models and clinical neuroblastoma.Clinical Validation of a Pixon-Based Reconstruction Method Allowing a Twofold Reduction in Planar Images Time of 111In-Pentetreotide Somatostatin Receptor Scintigraphy.A "false positive" octreoscan in ileal Crohn's disease.A single photon emission computed tomography of the chest with the use of receptor radiotracer (Tc-99m-Depreotide) in sarcoidosisUtility of indium-111 octreotide to identify a cardiac metastasis of a carcinoid neoplasm.Quantitative assessment of (99m)tc-depreotide uptake in oesophageal cancer and precursor conditions and its reflection in immunohistochemically detected somatostatin receptors.Somatostatin receptor-based molecular imaging and therapy for neuroendocrine tumors.Somatostatin receptor expression in lymphomas: a source of false diagnosis of neuroendocrine tumor at 68Ga-DOTANOC PET/CT imaging.111In-pentetreotide scintigraphy in medulloblastoma: a comparison with magnetic resonance imaging.Is there a clinical usefulness for radiolabeled somatostatin analogues beyond the consolidated role in NETs?Correlation between 99mTc-HYNIC-octreotide SPECT/CT somatostatin receptor scintigraphy and pathological grading of meningioma.SPECT/CT hybrid imaging with 111In-pentetreotide in assessment of neuroendocrine tumours.Primary hepatic neuroendocrine neoplasm: Long-time surgical outcome and prognosis
P2860
Q24614827-C6F43E02-B5DD-440E-A6DB-DBF514E1A99BQ30472127-FDB80B83-EB92-47C0-A6C4-2851329A7687Q31164247-4CF6E19B-E8E2-47E1-AAC3-CFC5F575FA12Q33526620-AD06682B-4C94-4A2B-A67A-B10FA2595A96Q33846924-2578A937-EBB9-4A7D-A497-D099F336F9C4Q33883667-2A4E505F-B7D0-4DB6-AF06-031BFF32BB40Q35049485-0F35376E-9814-4AD5-9A28-B9E75CA77697Q35169422-B351DCE3-DC71-49D0-BF13-F5A33A6E7B7CQ35891227-1E844AAB-D931-46CB-9AAE-BE17C1C8E5E4Q36008285-95409F75-5D2F-40D5-9744-AB987D8A17F2Q36125208-060E393D-6D3E-4625-9FE8-C8D53E80581CQ36343599-E26AD49C-51B4-4DC5-9706-1D6F053B2E20Q36914468-AFE90879-5FAF-4FA7-94F7-43B5D1ABCD58Q37077358-3FFDD0A4-D66D-48D3-9ACB-9B3C3F5390BBQ37990407-1F85E1D9-8BFB-4418-81FD-8A6FA9FB1449Q37994083-4BFFAECC-DDA9-462D-A36A-D7A874B6EF95Q38019458-8D6956EA-B402-49B1-8C64-6C1CEAF69EDBQ38788272-4E3C1E10-B5D4-4FF7-95D2-0F911525581FQ38903218-976D91DC-E038-4519-8E30-1BB1AF025715Q39251726-280B4F2E-C703-4700-BB76-F0D2068E8B6FQ39596829-C1C63FDE-8935-464C-95DA-60ADF7EA80D4Q41608646-83E78301-1372-49A9-B290-AD498F6E5D51Q41873821-58CC99A7-8E18-4E00-B106-732034D428ABQ41916779-DA6FDC19-9A19-4CE0-9E32-996F6FCF652FQ42010229-CD8BD540-A12E-4CEE-B1A5-137FB7944B3BQ42542651-9FFBB627-60AC-4FC2-9890-5DFA68F013F9Q42548064-156D0196-93EE-4A07-8D6F-1144A3B6450BQ48160156-2D882B87-365D-4185-8335-6681E03D7199Q48200381-66F86C84-6F75-463F-80F4-8D128CD2391DQ49353240-36A7C8D2-50A3-41B8-B96D-F7A2755ACC9EQ51009564-B5A4A7FB-6238-4959-8F8A-991804F49C1CQ53638311-8DE9CA2E-1879-4B9D-AB2E-3D2459647DCDQ58801989-8E2B66D1-4B63-4C81-ACCE-9A6DC6E38A9D
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Somatostatin receptor imaging.
@ast
Somatostatin receptor imaging.
@en
Somatostatin receptor imaging.
@nl
type
label
Somatostatin receptor imaging.
@ast
Somatostatin receptor imaging.
@en
Somatostatin receptor imaging.
@nl
prefLabel
Somatostatin receptor imaging.
@ast
Somatostatin receptor imaging.
@en
Somatostatin receptor imaging.
@nl
P356
P1476
Somatostatin receptor imaging.
@en
P2093
Dik J Kwekkeboom
Eric P Krenning
P356
10.1053/SNUC.2002.31022
P577
2002-04-01T00:00:00Z